Open AccessMenopausal Hormone Therapy and Risk of Diverticulitis
Author(s) -
Manol Jovani,
Wenjie Ma,
Amit D. Joshi,
PoHong Liu,
Long H. Nguyen,
Yin Cao,
Idy Tam,
Kana Wu,
Edward Giovannucci,
Andrew T. Chan,
Lisa L. Strate
Publication year - 2019
Publication title -
the american journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.907
H-Index - 252
eISSN - 1572-0241
pISSN - 0002-9270
DOI - 10.14309/ajg.0000000000000054
Subject(s) - medicine , diverticulitis , hazard ratio , proportional hazards model , lower risk , body mass index , confidence interval
Diverticulitis is a significant cause of morbidity among older women, and little attention has been paid to understanding its etiology. We have shown that menopausal hormone therapy (MHT) is associated with the risk of inflammatory bowel disease. In this study, we prospectively examined the association between MHT and the risk of incident diverticulitis.